| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/13/2000 | EP1035110A1 Benzylaminodiacetamide derivatives, compositions containing the same, process for their preparation and uses |
| 09/13/2000 | EP1034780A2 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 09/13/2000 | EP1034326A1 Process for the production of protein fibres and products thereof |
| 09/13/2000 | EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1033980A1 Skin care composition |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1266421A Anti-cancer compounds |
| 09/13/2000 | CN1266370A Activated vitamin D3 emulsion-type lotions |
| 09/13/2000 | CN1265914A Dressing liquid for treating burn and scald and preparation process thereof |
| 09/13/2000 | CN1265881A Shampoo compositions |
| 09/13/2000 | CN1056303C Zaohuang ointment for treating burn and preparation process thereof |
| 09/13/2000 | CN1056298C External medicine for treating soft tissue injury and production process thereof |
| 09/13/2000 | CN1056295C Tradtional Chinese medicine for balancing internal secretion |
| 09/13/2000 | CN1056285C Medicine containing extract from flowers of salvia officinalis |
| 09/13/2000 | CN1056281C Medicine for treating burn and preparation process thereof |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117895 Dialkoxyphenyl-substituted oxazolidinones |
| 09/12/2000 | US6117864 Methods employing stable preparation containing azelastine hydrochloride |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/12/2000 | US6117119 Gelatinous body protection article having a therapeutic additive |
| 09/12/2000 | CA2064476C Podophyllotoxin preparation containing triglycerides |
| 09/08/2000 | WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052013A2 Thiazoloindolinone compounds |
| 09/08/2000 | WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051718A1 Chemical method for making pyrithione particle dispersions |
| 09/08/2000 | WO2000051640A1 Itchiness-relieving agents and itchiness-relieving effect potentiators |
| 09/08/2000 | WO2000051605A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
| 09/08/2000 | WO2000051562A1 Matrix metalloprotease inhibitor and utilization thereof |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO1999053961A9 Peptides for efficient gene transfer |
| 09/08/2000 | WO1999034784A3 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 09/08/2000 | CA2363983A1 Chemical method for making pyrithione particle dispersions |
| 09/08/2000 | CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | CA2361580A1 Thiazoloindolinone compounds |
| 09/07/2000 | DE19754659C2 Verwendung von Kohlensäure zur Stabilisierung oder Erhöhung der epidermalen Ceramidsyntheserate Use of carbon dioxide for stabilizing or increasing the epidermal ceramide synthesis |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032671A1 Mammalian cytokine-like polypeptide-10 |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032656A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity |
| 09/06/2000 | EP1032405A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032386A1 Use of oxazolidinone derivatitives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032379A1 Composition with azelaic acid |
| 09/06/2000 | EP1032364A1 Topical compositions containing sialyl sugars and their derivatives |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0590015B1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265597A Composition comprising propolis and at least an essential oil |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265589A Enantiomers of 4-[[(cyanoimino)-[(1,2,2-trimethylpropyl) amino] methyl] amino] benzonitrile |
| 09/06/2000 | CN1265580A Skin whitener composition containing mercaptodextran |
| 09/06/2000 | CN1265320A Natural herbal medicine composition with the functions of stopping itching, disinfection and antiphlogosis and its preparation |
| 09/06/2000 | CN1265313A Dermatosis treating medicine |
| 09/06/2000 | CN1265312A Psoriasis treating medicine |
| 09/06/2000 | CN1265311A Alopecia treating medicine |
| 09/06/2000 | CN1265310A Acne treating medicine |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/06/2000 | CN1056075C Chinese medicine ointment |
| 09/06/2000 | CN1056065C Preparation for curing chilbain and preparing process thereof |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114559 Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof |
| 09/05/2000 | US6114533 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
| 09/05/2000 | US6114389 Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions |
| 09/05/2000 | US6114377 For topical application, comprising an antimicrobial effective amount of 3-furancarboxylic acid combined with 2-furancarboxylic acid and optionally ferulic acid as an antiirritant; free of preservatives |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114336 Cosmetic composition containing a neuropeptide Y receptor antagonist |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |